Long-Term Outcomes of a Drug-Eluting Resorbable Scaffold vs Angioplasty in Infrapopliteal Chronic Limb-Threatening Ischemia 3-Year Results From the LIFE-BTK Trial

Journal:

Journal of the American College of Cardiology

Published:

2026-05-14

DOI:

10.1016/j.jacc.2026.04.008

Affiliations:

22

Authors:

22

Go to article

Institutions	Authors	Share
Abbott, United States of America (USA)	5.000000	0.23
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)	2.000000	0.09
Advanced Heart And Vein Center, United States of America (USA)	1.000000	0.05
NewYork-Presbyterian / Weill Cornell Medical Center, United States of America (USA)	1.000000	0.05
Charlton Memorial Hospital, United States of America (USA)	1.000000	0.05
Ballad Health, United States of America (USA)	1.000000	0.05
Hackensack University Medical Center (Hackensack UMC), United States of America (USA)	1.000000	0.05
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)	1.000000	0.05
Mount Sinai Hospital, ISMMS, United States of America (USA)	1.000000	0.05
Osaka Keisatsu Hospital, Japan	1.000000	0.05
University Hospitals Cleveland Medical Center, CWRU, United States of America (USA)	1.000000	0.05
Department of General Surgery, Changi General Hospital, Singapore	1.000000	0.05
National Taiwan University Hospital (NTUH), Taiwan	1.000000	0.05
Prince of Wales Hospital, Australia	0.500000	0.02
University of New South Wales (UNSW Sydney), Australia	0.500000	0.02
Catholic Health Services of Long Island (CHS), United States of America (USA)	0.500000	0.02
St. Francis Hospital, United States of America (USA)	0.500000	0.02
Syntropic CoreLab, United States of America (USA)	0.500000	0.02
OhioHealth, United States of America (USA)	0.500000	0.02
The University of Auckland, New Zealand	0.500000	0.02
Auckland City Hospital (ACH), New Zealand	0.500000	0.02

Interested in Cardiovascular Medicine and Haematology?